Agilent Technologies, Inc. $A is Impax Asset Management Group plc's 6th Largest Position

Key Points

• Impax Asset Management trimmed its stake in Agilent by 12.4% in Q4, selling 366,199 shares and now holds 2,595,597 shares (about 0.92% of Agilent) worth roughly $353.2 million, making Agilent its 6th-largest holding.
• Agilent reported Q1 EPS of $1.36 (missed by $0.01) on revenue of $1.80 billion (+7% YoY) and set FY2026 guidance of $5.90–6.04 EPS with Q2 guidance of $1.39–1.42.
• Several analysts have trimmed price targets (e.g., TD Cowen to $157, UBS to $165, Barclays to $140) but the consensus remains a Buy with an average target of $163.71; shares trade near $115.60 with a $32.67B market cap.

Impax Asset Management Group plc trimmed its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 12.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,595,597 shares of the medical research company's stock after selling 366,199 shares during the quarter. Agilent Technologies accounts for 2.2% of Impax Asset Management Group plc's holdings, making the stock its 6th largest holding. Impax Asset Management Group plc owned about 0.92% of Agilent Technologies worth $353,183,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Brighton Jones LLC raised its position in shares of Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock worth $626,000 after acquiring an additional 270 shares in the last quarter. Jones Financial Companies Lllp raised its position in shares of Agilent Technologies by 15.9% in the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company's stock worth $602,000 after acquiring an additional 769 shares in the last quarter. Geneos Wealth Management Inc. raised its position in shares of Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company's stock worth $70,000 after acquiring an additional 212 shares in the last quarter. Acadian Asset Management LLC raised its position in shares of Agilent Technologies by 16.5% in the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company's stock worth $625,000 after acquiring an additional 758 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new position in shares of Agilent Technologies in the 2nd quarter worth $273,000.

Analyst Ratings Changes

A has been the subject of several recent research reports. TD Cowen reduced their price target on Agilent Technologies from $170.00 to $157.00 and set a "buy" rating for the company in a research report on Thursday, February 26th. UBS Group reduced their target price on Agilent Technologies from $180.00 to $165.00 and set a "buy" rating on the stock in a research report on Thursday, February 26th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Agilent Technologies in a research report on Monday, December 29th. Wells Fargo & Company reduced their target price on Agilent Technologies from $175.00 to $165.00 and set an "overweight" rating on the stock in a research report on Thursday, February 26th. Finally, Barclays reduced their target price on Agilent Technologies from $150.00 to $140.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 14th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of $163.71.

Agilent Technologies Stock Up 1.0%

Shares of A opened at $115.60 on Friday. Agilent Technologies, Inc. has a 52 week low of $104.10 and a 52 week high of $160.27. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $32.67 billion, a price-to-earnings ratio of 25.52, a PEG ratio of 2.41 and a beta of 1.30. The stock's 50-day moving average price is $117.25 and its 200-day moving average price is $133.22.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts' consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The company had revenue of $1.80 billion during the quarter, compared to analysts' expectations of $1.81 billion. During the same quarter in the previous year, the company earned $1.31 EPS. The firm's quarterly revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 5.95 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st were given a dividend of $0.255 per share. The ex-dividend date was Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. Agilent Technologies's dividend payout ratio is currently 22.52%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.